ArticleThrombosis journal2026
Perioperative inflammatory and coagulation biomarkers for predicting venous thromboembolism after lower limb fracture surgery.
Article in Thrombosis journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundVenous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable but serious postoperative complication in patients with lower limb fractures. Despite prophylactic measures, incidence remains high due to the interplay of trauma, immobility, and systemic inflammation. Biomarkers such as D-dimer, C-reactive protein (CRP), interleukin-6 (IL-6),and neutrophil-to-lymphocyte ratio (NLR), along with clinical recovery parameters, may improve prediction but remain under-integrated in orthopedic trauma risk models.
methodsA retrospective observational study was conducted in 106 patients undergoing surgical fixation for lower limb fractures between 2021 and 2024. All patients received risk-stratified VTE prophylaxis per Caprini score and institutional guidelines. Perioperative blood samples were collected preoperatively and on postoperative days 1, 3, and 5 to measure inflammatory, hematologic, and coagulation parameters. Clinical and surgical data, including ambulation timing and hospital stay, were recorded. VTE diagnosis was symptom-triggered and confirmed via Doppler ultrasonography or computed tomography pulmonary angiography (CTPA). Statistical analyses included logistic regression with odds ratio (OR), calibration testing, and receiver operating characteristic (ROC) analysis.
resultsTwenty-one patients (19.8%) developed VTE. Significant risk factors included advanced age, hypertension, femoral fractures, delayed ambulation, and prolonged hospitalization. Biomarkers such as CRP, IL-6, tumour necrosis factor-α (TNF-α), D-dimer, NLR, and fibrinogen were consistently higher in VTE patients, particularly on postoperative Day 3. Multivariate analysis identified age (OR 1.05, 95% CI 1.01–1.10), hypertension (OR 2.41, 95% CI 1.01–5.76), delayed ambulation (OR 3.26, 95% CI 1.22–8.70), and elevated D-dimer (OR 1.32, 95% CI 1.08–1.63) as independent predictors. ROC analysis demonstrated strongest performance for D-dimer [area under the curve (AUC) 0.78], while a combined biomarker model integrating D-dimer, CRP, IL-6, NLR, and fibrinogen improved discrimination [AUC 0.86, sensitivity 81.0%, specificity 79.5%, negative predictive value (NPV) 93.2]. Calibration plots and decision curve analysis confirmed good model performance.
conclusionThis study demonstrates that perioperative biomarkers, particularly when integrated with recovery parameters such as ambulation delay, enhance prediction of postoperative VTE in orthopedic trauma patients. While findings are exploratory due to limited events and symptom-triggered detection, the results highlight the translational potential of combined biomarker–clinical models. Development and external validation of trauma-specific nomograms are warranted to enable individualized prophylaxis and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.